Lanean...
BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy
Bruton’s tyrosine kinase (BTK) signaling is involved in innate immune responses and regulates the production of proinflammatory cytokines that can contribute to COVID-19 immunopathology. Clinical trials with BTK inhibitors in COVID-19 treatment have been proposed, and previous studies have attempted...
Gorde:
| Argitaratua izan da: | J Leukoc Biol |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Oxford University Press
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7361550/ https://ncbi.nlm.nih.gov/pubmed/32640487 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/JLB.5COVR0620-306R |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|